Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In the tesamorelin Phase 3 clinical trials, mean baseline (Week 0) HbA1c was 5.26% among patients in the tesamorelin group and 5.28% among those in the placebo group
mean CD4 cell count was 579 cells/mm3
What the Research Suggests A 2006 study published in the Journal of Clinical Endocrinology & Metabolism demonstrated that CJC-1295 "resulted in sustained, dose-dependent increases in GH and IGF-I levels in healthy adults and was safe and relatively well tolerated." Mean growth hormone concentrations increased by 2- to 10-fold for 6 days or more after a single injection
Frequently Asked Questions Questions are useful tools, they open lines of communication
US$ 22.12
US$ 29.23
US$ 22.70
US$ 25.07
US$ 21.82
US$ 29.38
